TOVX חוב לטווח קצר של החברה Theriva Corp

The Theriva Biologics, Inc. (TOVX) price chart demonstrates financial metrics where the debt load stands at 0.00. Stable management adheres to disciplined spending, confidently overseeing research operations. The business relies on the creation of viruses that disrupt the protective layer of pancreatic tumors to enable drug access. High profitability is driven by a flexible platform that allows for the low-cost production of innovative treatments on a global scale.

For Theriva Biologics, Inc. (TOVX), which lacks revenue and depends on external financing, the history of short-term debt changes serves as an indicator of critical liquidity. This metric aggregates all obligations with a maturity of up to one year, allowing for an assessment of default risk in the absence of new grants and determining capital stability amid high uncertainty in clinical developments.